{"title":"Laron syndrome presenting with severe low bone density for age in a 28-year-old woman: a case report.","authors":"Manoj Kumar Chaulagain, Devansh Joshi, Rachana Acharya, Rajendra Tamrakar","doi":"10.1097/MS9.0000000000005570","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Laron syndrome (LS) is a rare, autosomal recessive disorder of growth hormone insensitivity, characterized by proportional short stature and low concentrations of insulin-like growth factor-1 (IGF-1) despite normal or increased levels of growth hormone.</p><p><strong>Case presentation: </strong>A 28-year-old woman presented with proportional short stature and a markedly low body weight, with a BMI of 14.5 kg/m<sup>2</sup>. Physical examination revealed a characteristic phenotype, including a prominent forehead, saddle-shaped nose and blue-tinted sclera. Investigations revealed low serum IGF-1 levels with elevated levels of growth hormone. Severe vitamin D deficiency and secondary hyperparathyroidism were observed. Differentials of malnutrition and clinical hypothyroidism were systematically ruled out. Management was focused on closed fracture reduction, vitamin D and calcium supplementation, and physical rehabilitation of the patient.</p><p><strong>Clinical discussion: </strong>Based on the phenotypic presentation and endocrine profile of the patient, a clinical diagnosis of LS was formulated. Unlike common LS presentations, this patient was markedly underweight, suggesting ethnic and nutritional variations. The comorbid vitamin D deficiency likely acted as a disease modifier, exacerbating the skeletal complications in an already compromised skeletal system.</p><p><strong>Conclusion: </strong>This case underscores the importance of strong clinical acumen in diagnosing rare growth disorders, especially in resource-limited settings where confirmatory genetic testing is not readily available. It also highlights how secondary bone disturbances can exacerbate the presentation, leading to significant functional impairment.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"88 10","pages":"6792-6797"},"PeriodicalIF":1.6000,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13657528/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Medicine and Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/MS9.0000000000005570","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/10/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Laron syndrome (LS) is a rare, autosomal recessive disorder of growth hormone insensitivity, characterized by proportional short stature and low concentrations of insulin-like growth factor-1 (IGF-1) despite normal or increased levels of growth hormone.
Case presentation: A 28-year-old woman presented with proportional short stature and a markedly low body weight, with a BMI of 14.5 kg/m2. Physical examination revealed a characteristic phenotype, including a prominent forehead, saddle-shaped nose and blue-tinted sclera. Investigations revealed low serum IGF-1 levels with elevated levels of growth hormone. Severe vitamin D deficiency and secondary hyperparathyroidism were observed. Differentials of malnutrition and clinical hypothyroidism were systematically ruled out. Management was focused on closed fracture reduction, vitamin D and calcium supplementation, and physical rehabilitation of the patient.
Clinical discussion: Based on the phenotypic presentation and endocrine profile of the patient, a clinical diagnosis of LS was formulated. Unlike common LS presentations, this patient was markedly underweight, suggesting ethnic and nutritional variations. The comorbid vitamin D deficiency likely acted as a disease modifier, exacerbating the skeletal complications in an already compromised skeletal system.
Conclusion: This case underscores the importance of strong clinical acumen in diagnosing rare growth disorders, especially in resource-limited settings where confirmatory genetic testing is not readily available. It also highlights how secondary bone disturbances can exacerbate the presentation, leading to significant functional impairment.